Personnel Information

写真a

Fujiwara Motohiro


Job title

Graduate Student
To the head of this page.▲

Campus Career 【 display / non-display 】

  • 2015.04
    -
    2016.02
    Tokyo Medical and Dental University， Graduate School of Medical and Dental Sciences， Medical and Dental Sciences， Systemic Organ Regulation， Urology， Senior Resident
  • 2021.04
    -
    Now
    Tokyo Medical and Dental University， Graduate School of Medical and Dental Sciences， Medical and Dental Sciences， Division of Systemic Organ Regulation， Department of Urology， Graduate Student
  • 2021.04
    -
    Now
    Tokyo Medical and Dental University， Graduate School of Medical and Dental Sciences， Medical and Dental Sciences， Systemic Organ Regulation， Urology， Graduate Student
To the head of this page.▲
 

Published Papers & Misc 【 display / non-display 】

  1. Kataoka M, Yokoyama M, Waseda Y, Ito M, Kobayashi M, Fujiwara M, Nakamura Y, Ishikawa Y, Fukuda S, Tanaka H, Yoshida S, Masuda H, Fujii Y. Longitudinal deterioration in lower urinary tract symptoms after artificial urinary sphincter implantation in patients with a history of pelvic radiation therapy. Lower urinary tract symptoms. 2024.01; 16 (1): e12507. ( PubMed, DOI )

  2. Nakamura Yuki, Fukushima Hiroshi, Yoshitomi Kasumi, Soma Takahiko, Kobayashi Masaki, Fan Bo, Fujiwara Motohiro, Ishikawa Yudai, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Yokoyama Minato, Fujii Yasuhisa. 筋層非浸潤性膀胱癌の増悪予測における背側膀胱頸部浸潤の重要性(Significance of dorsal bladder neck involvement in predicting the progression of non-muscle-invasive bladder cancer) International Journal of Urology. 2023.04; 30 (4): 381-388. ( ichushi )

  3. Fujiwara Motohiro, Yokoyama Minato, Toide Masahiro, Fujiwara Ryo, Tanaka Hajime, Oguchi Tomohiko, Komai Yoshinobu, Yoshida Soichiro, Matsuoka Yoh, Numao Noboru, Yamamoto Shinya, Fukui Iwao, Yonese Junji, Fujii Yasuhisa. Renal function outcome after selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and consolidative partial cystectomy in comparison with radical cystectomy for patients with muscle-invasive bladder cancer: a two-centre retrospective stud) Japanese Journal of Clinical Oncology. 2023.03; 53 (3): 263-269. ( ichushi )

  4. Yuki Nakamura, Hiroshi Fukushima, Kasumi Yoshitomi, Takahiko Soma, Masaki Kobayashi, Bo Fan, Motohiro Fujiwara, Yudai Ishikawa, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Minato Yokoyama, Yasuhisa Fujii. Significance of dorsal bladder neck involvement in predicting the progression of non-muscle-invasive bladder cancer. Int J Urol. 2022.12; 30 (4): 381-388. ( PubMed, DOI )

  5. Ryo Fujiwara, Takeshi Yuasa, Shinya Yamamoto, Motohiro Fujiwara, Kosuke Takemura, Tetsuya Urasaki, Ryosuke Oki, Yoshinobu Komai, Tomohiko Oguchi, Noboru Numao, Junji Yonese. Geriatric Nutritional Risk Index as a Predictor of Prognosis in Metastatic Renal Cell Carcinoma Treated with Nivolumab. Nutr Cancer. 2022.11; 75 (2): 1-8. ( PubMed, DOI )

  6. Eri Fukagawa, Takeshi Yuasa, Kentaro Inamura, Kosuke Hamada, Motohiro Fujiwara, Yoshinobu Komai, Junji Yonese. large-cell neuroendocrine carcinoma of the prostate: A case report and literature review. IJU Case Rep. 2022.11; 5 (6): 505-510. ( PubMed, DOI )

  7. Fukagawa Eri, Yuasa Takeshi, Inamura Kentaro, Hamada Kosuke, Fujiwara Motohiro, Komai Yoshinobu, Yonese Junji. de novo前立腺大細胞神経内分泌癌　1症例報告と文献レビュー(De novo large-cell neuroendocrine carcinoma of the prostate: A case report and literature review) IJU Case Reports. 2022.11; 5 (6): 505-510. ( ichushi )

  8. Yuki Arita, Soichiro Yoshida, Keisuke Shigeta, Thomas C Kwee, Hiromi Edo, Naoko Okawara, Masahiro Hashimoto, Ryota Ishii, Ryo Ueda, Shuji Mikami, Motohiro Fujiwara, Yuma Waseda, Eiji Kikuchi, Yasuhisa Fujii, Masahiro Jinzaki. Diagnostic Value of the Vesical Imaging-Reporting and Data System in Bladder Urothelial Carcinoma with Variant Histology. Eur Urol Oncol. 2022.08; 6 (1): 99-102. ( PubMed, DOI )

  9. Kasumi Kaneko Yoshitomi, Yoshinobu Komai, Tatsuya Yamamoto, Eri Fukagawa, Kosuke Hamada, Yusuke Yoneoka, Motohiro Fujiwara, Ryo Fujiwara, Tomohiko Oguchi, Noboru Numao, Takeshi Yuasa, Shinya Yamamoto, Iwao Fukui, Junji Yonese. Improving Accuracy, Reliability, and Efficiency of the RENAL Nephrometry Score With 3D Reconstructed Virtual Imaging. Urology. 2022.06; 164 286-292. ( PubMed, DOI )

  10. Yoshitomi KK, Komai Y, Yamamoto T, Fukagawa E, Hamada K, Yoneoka Y, Fujiwara M, Fujiwara R, Oguchi T, Numao N, Yuasa T, Yamamoto S, Fukui I, Yonese J. Improving Accuracy, Reliability, and Efficiency of the RENAL Nephrometry Score With 3D Reconstructed Virtual Imaging Urology. 2022.06;

  11. Motohiro Fujiwara, Noboru Numao, Shinya Yamamoto, Yudai Ishikawa, Ryo Fujiwara, Tomohiko Oguchi, Yoshinobu Komai, Yoh Matsuoka, Takeshi Yuasa, Junji Yonese. Predictive ability of prebiopsy magnetic resonance imaging and biopsy for side-specific negative lymph node metastasis at radical prostatectomy. Prostate. 2022.06; 82 (8): 904-910. ( PubMed, DOI )

  12. Motohiro Fujiwara, Ryo Fujiwara, Tetsuya Urasaki, Tomohiko Oguchi, Yoshinobu Komai, Noboru Numao, Shinya Yamamoto, Junji Yonese, Takeshi Yuasa. Early Serum and Hematological Responses to Pembrolizumab Therapy as Predictors of Survival in Metastatic Urothelial Cancer. Anticancer Res. 2022.04; 42 (4): 2045-2051. ( PubMed, DOI )

  13. Motohiro Fujiwara, Ryo Fujiwara, Tomohiko Oguchi, Yoshinobu Komai, Noboru Numao, Shinya Yamamoto, Junji Yonese, Takeshi Yuasa. Clinical Outcome and Prognostic Variables of Second-line Therapy for Patients With Castration-resistant Prostate Cancer After Failure of First-line Androgen Receptor Axis-targeted Therapy. Anticancer Res. 2022.04; 42 (4): 2123-2130. ( PubMed, DOI )

  14. Yoshida S, Takahara T, Arita Y, Toda K, Kimura K, Fujiwara M, Tanaka H, Yokoyama M, Matsuoka Y, Yoshimura R, Fujii Y.. Patterns of recurrence in genuine and induced oligometastatic castration-resistant prostate cancer treated with progressive site-directed therapy. Int J Urol. 2022;

  15. Fujiwara M, Yuasa T, Urasaki T, Komai Y, Fujiwara R, Numao N, Yamamoto S, Yonese J. Effectiveness and safety profile of pembrolizumab for metastatic urothelial cancer: A retrospective single-center analysis in Japan. Cancer reports (Hoboken, N.J.). 2021.12; 4 (6): e1398. ( PubMed, DOI )

  16. Motohiro Fujiwara, Hajime Tanaka, Takeshi Yuasa, Yoshinobu Komai, Tomohiko Oguchi, Ryo Fujiwara, Noboru Numao, Shinya Yamamoto, Yasuhisa Fujii, Iwao Fukui, Junji Yonese. First-line combination chemotherapy with etoposide, ifosfamide and cisplatin for the treatment of disseminated germ cell cancer: Efficacy and feasibility in current clinical practice. Int J Urol. 2021.09; 28 (9): 920-926. ( PubMed, DOI )

  17. Fujiwara Motohiro, Tanaka Hajime, Yuasa Takeshi, Komai Yoshinobu, Oguchi Tomohiko, Fujiwara Ryo, Numao Noboru, Yamamoto Shinya, Fujii Yasuhisa, Fukui Iwao, Yonese Junji. 播種性胚細胞癌に対するエトポシド、イホスファミド、シスプラチンによるファーストライン併用化学療法　現在の臨床現場における有効性と実施可能性(First-line combination chemotherapy with etoposide, ifosfamide and cisplatin for the treatment of disseminated germ cell cancer: Efficacy and feasibility in current clinical practice) International Journal of Urology. 2021.09; 28 (9): 920-926. ( ichushi )

  18. Fukagawa Eri, Yamamoto Shinya, Ohde Sachiko, Kaneko-Yoshitomi Kasumi, Hamada Kosuke, Yoneoka Yusuke, Fujiwara Motohiro, Fujiwara Ryo, Oguchi Tomohiko, Komai Yoshinobu, Numao Noboru, Yuasa Takeshi, Fukui Iwao, Yonese Junji. 高リスクの臨床的限局性前立腺癌患者における拡大骨盤内リンパ節郭清の候補者を特定するためのBriganti 2019ノモグラムの外部検証(External validation of the Briganti 2019 nomogram to identify candidates for extended pelvic lymph node dissection among patients with high-risk clinically localized prostate cancer) International Journal of Clinical Oncology. 2021.09; 26 (9): 1736-1744. ( ichushi )

  19. Kaneko Yoshitomi Kasumi, Numao Noboru, Umino Yosuke, Fujiwara Motohiro, Fujiwara Ryo, Oguchi Tomohiko, Komai Yoshinobu, Yuasa Takeshi, Yamamoto Shinya, Yonese Junji. 胚細胞癌の転移巣検出における背景抑制広範囲拡散強調画像の有用性(The utility of diffusion-weighted whole-body imaging with background body signal suppression in detecting metastatic lesion of germ cell carcinoma) IJU Case Reports. 2021.09; 4 (5): 285-288. ( ichushi )

  20. Fukagawa E, Yamamoto S, Ohde S, Yoshitomi KK, Hamada K, Yoneoka Y, Fujiwara M, Fujiwara R, Oguchi T, Komai Y, Numao N, Yuasa T, Fukui I, Yonese J. External validation of the Briganti 2019 nomogram to identify candidates for extended pelvic lymph node dissection among patients with high-risk clinically localized prostate cancer. International journal of clinical oncology. 2021.09; 26 (9): 1736-1744. ( PubMed, DOI )

  21. Fujiwara M, Yuasa T, Yasuoka S, Komai Y, Oguchi T, Fujiwara R, Numao N, Yamamoto S, Yonese J. Serum and hematologic responses after three cycles of cabazitaxel therapy as predictors of survival in castration-resistant prostate cancer. Cancer chemotherapy and pharmacology. 2021.09; 88 (3): 525-531. ( PubMed, DOI )

  22. Yoshitomi KK, Numao N, Umino Y, Fujiwara M, Fujiwara R, Oguchi T, Komai Y, Yuasa T, Yamamoto S, Yonese J. The utility of diffusion-weighted whole-body imaging with background body signal suppression in detecting metastatic lesion of germ cell carcinoma. IJU case reports. 2021.09; 4 (5): 285-288. ( PubMed, DOI )

  23. Yasuoka S, Yuasa T, Fujiwara M, Fujisaki J, Inamura K, Komai Y, Numao N, Yamamoto S, Yonese J. Unusual metastasis from renal cell cancer after partial nephrectomy and sequential targeted therapy. IJU case reports. 2021.05; 4 (3): 136-138. ( PubMed, DOI )

  24. Yasuoka Shotaro, Yuasa Takeshi, Fujiwara Motohiro, Fujisaki Junko, Inamura Kentaro, Komai Yoshinobu, Numao Noboru, Yamamoto Shinya, Yonese Junji. 腎部分切除術および逐次標的治療後の腎細胞癌から稀な転移をきたした1例(Unusual metastasis from renal cell cancer after partial nephrectomy and sequential targeted therapy) IJU Case Reports. 2021.05; 4 (3): 136-138. ( ichushi )

  25. Fujiwara R, Takemura K, Fujiwara M, Yuasa T, Yasuoka S, Komai Y, Numao N, Yamamoto S, Yonese J. Modified Glasgow Prognostic Score as a Predictor of Prognosis in Metastatic Renal Cell Carcinoma Treated With Nivolumab. Clinical genitourinary cancer. 2021.04; 19 (2): e78-e83. ( PubMed, DOI )

  26. Fujiwara M, Yuasa T, Komai Y, Fujiwara R, Oguchi T, Numao N, Yamamoto S, Yonese J. Switching Patients With Prostate Cancer from GnRH Antagonist to Long-acting LHRH Agonist for Androgen Deprivation: Reducing Hospital Visits During the Coronavirus Pandemic. Cancer diagnosis & prognosis. 2021.03; 1 (1): 1-5. ( PubMed, DOI )

  27. Fujiwara M, Hayashi T, Takeda H, Yuasa T, Komai Y, Numao N, Yamamoto S, Fukui I, Kouno T, Yonese J. Cisplatin, Gemcitabine, and Paclitaxel as a Salvage Second-Line Therapy for Metastatic Germ-Cell Cancer. Clinical genitourinary cancer. 2021.02; 19 (1): e6-e11. ( PubMed, DOI )

  28. Urasaki T, Ono M, Mochizuki T, Takeda K, Nishizawa A, Fukagawa E, Fujiwara M, Komai Y, Kitano S, Yuasa T, Yonese J, Takahashi S. Case Report: A Case of Trimethoprim/Sulfamethoxazole-Triggered Hypotensive Shock: Cytokine Release Syndrome Related to Immune Checkpoint Inhibitors and Drug-Induced Hypersensitivity Syndrome. Frontiers in oncology. 2021; 11 681997. ( PubMed, DOI )

  29. Fujiwara Motohiro, Kawamura Naoko, Okuno Tetsuo. 膀胱全摘除術・回腸導管造設術後の早期および中期の腎機能予後(Renal function outcomes in the early and intermediate phases after radical cystectomy by ileal conduit) Journal of Rural Medicine. 2020.10; 15 (4): 178-182. ( ichushi )

  30. Fujiwara M, Yuasa T, Komai Y, Numao N, Yamamoto S, Fukui I, Yonese J. Efficacy, Prognostic Factors, and Safety Profile of Enzalutamide for Non-metastatic and Metastatic Castration-Resistant Prostate Cancer: A Retrospective Single-Center Analysis in Japan. Targeted oncology. 2020.10; 15 (5): 635-643. ( PubMed, DOI )

  31. Sano Y, Fujiwara M, Yuasa T, Komai Y, Yamamoto T, Kohno A, Nakao M, Inamura K, Yonese J. Testicular seminoma with a progressing pulmonary nodule and mediastinal lymphadenopathy without retroperitoneal metastasis. IJU case reports. 2020.09; 3 (5): 211-214. ( PubMed, DOI )

  32. Sano Yuta, Fujiwara Motohiro, Yuasa Takeshi, Komai Yoshinobu, Yamamoto Tatsuya, Kohno Atsushi, Nakao Masayuki, Inamura Kentaro, Yonese Junji. 肺の結節病変と縦隔リンパ節腫大が進行し続けたが後腹膜転移はみられなかった精巣のセミノーマの1例(Testicular seminoma with a progressing pulmonary nodule and mediastinal lymphadenopathy without retroperitoneal metastasis) IJU Case Reports. 2020.09; 3 (5): 211-214. ( ichushi )

  33. Fujiwara M, Komai Y, Yuasa T, Numao N, Yamamoto S, Fukui I, Yonese J. Pembrolizumab for a patient with metastatic castration-resistant prostate cancer with microsatellite instability-high. IJU case reports. 2020.03; 3 (2): 62-64. ( PubMed, DOI )

  34. Fujiwara Motohiro, Komai Yoshinobu, Yuasa Takeshi, Numao Noboru, Yamamoto Shinya, Fukui Iwao, Yonese Junji. マイクロサテライト不安定性が高い転移性去勢抵抗性前立腺癌患者に対するペムブロリズマブ投与(Pembrolizumab for a patient with metastatic castration-resistant prostate cancer with microsatellite instability-high) IJU Case Reports. 2020.03; 3 (2): 62-64. ( ichushi )

  35. Toide Masahiro, Yokoyama Minato, Fujiwara Motohiro, Kijima Toshiki, Saito Kazutaka, Fujii Yasuhisa. 筋層浸潤膀胱癌患者に対する膀胱温存療法後の腎機能　最大経尿道的切除術、導入化学放射線療法、膀胱部分切除術からなる選択的膀胱温存4者併用療法の成績(Renal function after bladder-preserving therapy for patients with muscle-invasive bladder cancer: Results of selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and partial cystectomy) International Journal of Urology. 2019.10; 26 (10): 1010-1012. ( ichushi )

  36. Fujiwara Motohiro, Kawamura Naoko, Okuno Tetsuo. 腎静脈に伸展する腎血管筋脂肪腫を認める患者における肺脂肪塞栓症の予防のための術前下大静脈フィルター留置　1症例報告と文献レビュー(Preoperative inferior vena cava filter implantation to prevent pulmonary fat embolism in a patient showing renal angiomyolipoma extension into the renal vein: A case report and literature review) Journal of Rural Medicine. 2018.11; 13 (2): 181-184. ( ichushi )

▼display all

To the head of this page.▲

Conference Activities & Talks 【 display / non-display 】

  1. Yoshida Souichirou, Takahara Taro, Arita Yuki, Toda Kazuma, Kimura Koichiro, Fujiwara Motohiro, Tanaka Hajime, Yokoyama Minato, Matsuoka Yoh, Yoshimura Ryoichi, Fujii Yasuhisa. Patterns of recurrence in genuine and induced oligometastatic castration-resistant prostate cancer treated with progressive site-directed therapy. the 110th Annual Meeting of the Japanese Urological Association 2023.04.01

  2. Fujiwara Motohiro, Yoshida Soichiro, Takahara Taro, Soma Takahiko, Yoshitomi Kasumi, Nakamura Yuki, Fan Bo, Ishikawa Yudai, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Yokoyama Minato, Fujii Yasuhisa. Prostate and Metastasis Diffusion Volume Based on Apparent Diffusion Coefficient as a Prognostic Factor in Hormone-naieve Prostate Cancer. the 110th Annual Meeting of the Japanese Urological Association 2023.04.01

  3. Y. Ishikawa, S. Uehara, K. Ishihara, K. Hirose, T. Soma, M. Fujiwara, M. Kobayashi, B. Fan, Y. Nakamura, Y. Uchida, S. Fukuda, H. Tanaka, S. Yoshida, M. Yokoyama, Y. Matsuoka, Y. Fujii. Variability in diagnostic performance of non-muscle invasive bladder cancer for each region using 8uorescence cystoscopy with orally administered 5-aminolevulinic acid. 37th Annual EAU Congress 2022 European Association of Urology 2022.07.01

  4. Y. Ishikawa, S. Uehara, K. Ishihara, K. Hirose, T. Soma, M. Fujiwara, M. Kobayashi, B. Fan, Y. Nakamura, Y. Uchida, S. Fukuda, H. Tanaka, S. Yoshida, M. Yokoyama, Y. Matsuoka, Y. Fujii. Orally administered 5-aminolevulinic acid can cause intraoperative hypotension in patients with bladder cancer undergoing transurethral resection. 37th Annual EAU Congress 2022 European Association of Urology 2022.07.01

  5. Ishikawa Y, Sho U, Ishihara K, Hirose K, Soma T, Fujiwara M, Kobayashi M, Fan B, Nakamura Y, Uchida Y, Fukuda S, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y. Orally administered 5-aminolevulinic acid can cause intraoperative hypotension in patients with bladder cancer undergoing transurethral resection. the 37th Annual European Association of Urology(EAU) Congress 2022.07

  6. Ishikawa Y, Uehara S, Ishihara K, Hirose K, Soma T, Fujiwara M, Kobayashi M, Fan B, Nakamura Y, Uchida Y, Fukuda S, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y. Variability in diagnostic performance of non-muscle invasive bladder cancer for each region using fluorescence cystoscopy with orally administered 5-aminolevulinic acid. the 37th Annual European Association of Urology(EAU) Congress 2022.07

  7. Komai Yoshinobu, Fujiwara Motohiro, Yasuoka Shotaro, Fujiwara Ryo, Ogawa Masahiro, Numao Noboru, Yuasa Takeshi, Yamamoto Shinya, Yonese Junji. ソフト凝固を用いたクラッシュカービング手術　腎機能低下を最小化した腹腔鏡的部分腎切除術を成功させるための簡単な方法(The crush-carving technique using a soft coagulation: A simple method to achieve successful laparoscopic partial nephrectomy with minimal renal function decrease). 日本泌尿器科学会総会 2020.12.01

  8. Fujiwara M et al.. Feasibility of non-use of antimicrobial prophylaxis in minimally invasive. 米国泌尿器科学会（annual meeting of the American Urological Association） 2016.05.07 San diego, USA

  9. Numao N et al. Optimal combination of MRI-targeted biopsy and systematic biopsy for men with suspicion of prostate cancer. . 米国泌尿器科学会（annual meeting of the American Urological Association） 2016.05.06 San diego, USA

  10. Fujiwara M et al.. Antibiotic prophylaxis is avoidable in minimally invasive clean surgery for renal or adrenal tumors: A prospective study of 678 cases. Munich, Germany 2016.03.12 Munich, Germany

▼display all

To the head of this page.▲